Guidelines of the National Comprehensive Cancer Network on the Use of Myeloid Growth Factors with Cancer Chemotherapy: A Review of the Evidence

By Lyman Gary H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 4, 2005-07 ,pp. : 557-571

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal of the published literature and National Comprehensive Cancer Network guidelines

By Sinha Parul   Piccirillo Jay F.   Kallogjeri Dorina   Spitznagel Edward L.   Haughey Bruce H.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1747-1754

Blackwell Publishing

Access to resources Recommend Favorite

Emerging immunosuppressive drugs in myelodysplastic syndromes

By Epling-Burnette Pearlie K   McDaniel Jessica   Wei Sheng   List Alan F  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 4, 2012-12 ,pp. : 519-541

Informa Healthcare

Access to resources Recommend Favorite

Drugs Used to Treat Spasticity

By Kita M.   Goodkin D.E.  

Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. : 487-495

Adis International

Access to resources Recommend Favorite

Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 4, 2003-11 ,pp. : 456-456

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite